Olink Proteomics AB
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 14, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,883,848 | Regulation Analysis by Cis Reactivity, Racr In force · High confidence | In force | High confidence | |
| US 8,268,554 | Method for analyte detection using proximity probes In force · From the USPTO record | In force | From the USPTO record | |
| US 10,731,206 | Exonuclease enabled proximity extension assays In force · From the USPTO record | In force | From the USPTO record | |
| US 9,777,315 | Exonuclease enabled proximity extension assays In force · From the USPTO record | In force | From the USPTO record | |
| US 9,677,131 | Blocking reagent and methods for the use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,902,993 | Hyperthermophilic polymerase enabled proximity extension assay In force · From the USPTO record | In force | From the USPTO record | |
| US 10,781,473 | Method for generating proximity probes In force · From the USPTO record | In force | From the USPTO record | |
| US D1,091,599 | Display Screen or Portion Thereof with Graphical User Interface In force · High confidence | In force | High confidence | |
| US 12,534,751 | Products for Protein Analyte Detection Assays Using Antibodies In force · Medium confidence | In force | Medium confidence | |
| US 12,540,355 | Nucleic Acid Reporter Molecules for Massively Parallel DNA Sequencing In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 10: 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 2 no status recorded